Association between smoking behavior patterns and chronic obstructive pulmonary disease: A long-term follow-up study among Finnish adults

Annals of Medicine

Volumn 44, Issue 6, 2012, Pages 598-606

  Hukkinen, Maria ^a,b   Korhonen, Tellervo ^a,b   Heikkilä, Kauko ^a   Kaprio, Jaakko ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

COPD; Longitudinal study; Smoking

Indexed keywords

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMPARATIVE STUDY; EMPHYSEMA; FEMALE; FINLAND; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SURVIVAL;

ADMINISTRATION, INHALATION; ADULT; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; COMORBIDITY; DRUG UTILIZATION REVIEW; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING; SURVIVAL ANALYSIS;

EID: 84865626735     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2011.580776     Document Type: Article

References (31)

1. Global Initiative of Chronic Obstructive Pulmonary Disease (GOLD). Global Strategy for Diagnosis, Management and Prevention of COPD. Updated in 2010. Accessed 11 May 2011.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-73. (Pubitemid 47321908)
3. Wan ES, Silverman EK. Genetics of COPD and emphysema. Chest. 2009;136:859-66.
4. Pietinalho A, Kinnula VL, Sovijärvi AR, Vilkman S, Säynäjäkangas O, Liippo K, et al. Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report. Respir Med. 2007;101:1419-25. (Pubitemid 46844681)
5. Kotaniemi J. Asthma, chronic obstructive pulmonary disease and respiratory symptoms among adults: prevalence and risk factors - The FinEsS Study in Northern Finland [thesis]. Helsinki: University of Helsinki; 2006. Available at: https://oa.doria.fi/bitstream/handle/10024/2032/asthmach.pdf? sequence+1. Accessed 11 May 2011.
6. Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003;97:115-22. (Pubitemid 36284990)
7. Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005;14:315-20. (Pubitemid 41396479)
8. Korhonen T, Broms U, Levälahti E, Koskenvuo M, Kaprio J. Characteristics and health consequences of intermittent smoking: Long-term follow-up among Finnish adult twins. Nicotine Tob Res. 2009;11:148-55.
9. Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res. 2007;9:631-46. (Pubitemid 46930313)
10. Fagerström, K. Smoking reduction in the management of COPD. Monaldi Arch Chest Dis. 2002;57:281-4. (Pubitemid 36637243)
11. Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med. 2010;16:97-105.
12. Gross NJ. Anticholinergic agents in asthma and COPD. Eur J Pharmacol. 2006;533:36-9. (Pubitemid 43340003)
13. Kinnula V, Tukiainen P, Katajisto M, Keistinen T, Tikkanen H, Sovijärvi A; Working group appointed by the Finnish Medical Society Duodecim and the Finnish Respiratory Society. Käypä hoito-suositus: Keuhkoahtaumatauti (English summary: Chronic Obstructive Pulmonary Disease, Diagnosis and Treatment). Updated in 2009. Accessed 11 May 2011.
14. Pauwels R. Global initiative for chronic obstructive lung diseases (GOLD): time to act. Eur Respir J. 2001;18:901-2. (Pubitemid 34092860)
15. Jousilahti P, Komulainen J, Hanski T, Kaila M, Ketola E. Perusterveydenhuollon lääkärit tuntevat hyvin Käypä Hoitosuositukset (English summary: Knowledge of, attitudes to, and use of current care guidelines among Finnish primary health care physicians). Finnish Medical Journal. 2007;62:3319-23.
16. Okuyemi KS, Harris KJ, Scheibmeir M, Choi WS, Powell J, Ahluwalia JS. Light smokers: issues and recommendations. Nicotine Tob Res. 2002;4(Suppl 2): S103-12. (Pubitemid 36104367)
17. Hukkinen M, Kaprio J, Broms U, Koskenvuo M, Korhonen T. Characteristics and consistency of light smoking: Longterm follow-up among Finnish adults. Nicotine Tob Res. 2009;11:797-805.
18. Shiffman S, Kassel JD, Paty J, Gnys M, Zettler-Segal M. Smoking typology profiles of chippers and regular smokers. J Subst Abuse. 1994;6:21-35.
19. Hukkinen M, Korhonen T, Broms U, Koskenvuo M, Kaprio J. Long-term smoking behavior patterns predicting self-reported chronic bronchitis. COPD. 2009;6:242-9.
20. Kujala UM, Kaprio J, Koskenvuo M. Modifiable risk factors as predictors of all-cause mortality: the roles of genetics and childhood environment. Am J Epidemiol. 2002;156:985-93. (Pubitemid 35396927)
21. British Medical Research Council; Medical Research Council's Committee on the aetiology of chronic bronchitis. Standardised questionnaires on respiratory symptoms. British Medical Journal. 1960; ii: 1665.
22. Laitinen LA, Koskela K. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998-2007. Respir Med. 1999;93:297-332. (Pubitemid 29211865)
23. Finland's Social Insurance Institution's decisions on medical conditions for specially reimbursed medications (in Finnish). Updated 6 Sep. 2010. Available at: http://www.kela.fi/in/internet/suomi.nsf/NET/270308131720KA? OpenDocument. Accessed 11 May 2011.
24. Martikainen J, Rajaniemi S. Drug reimbursement systems in EU Member States, Iceland and Norway. 2002. Available at: http://helda.helsinki.fi/ bitstream/handle/10138/13932/Drug-reimbursement.pdf?sequence+1. Accessed 11 May 2011.
25. The Social Insurance Institution of Finland: Guide to benefits. 2010. Available at: http://www.kela.fi/in/internet/liite.nsf/NET/180808091909HS/ $File/Pahkina-eng.pdf?OpenElement. Accessed 11 May 2011.
26. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.; 2009.
27. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645-6. (Pubitemid 30422662)
28. Amigo H, Oyarzun MG, Bustos P, Rona RJ. Respiratory consequences of light and moderate smoking in young adults in Chile. Int J Tuberc Lung Dis. 2006;10:744-9. (Pubitemid 44031387)
29. Vartiainen E, Seppälä T, Lillsunde P, Puska P. Validation of self-reported smoking by serume cotinine measurement in a community-based study. J Epidemiol Community Health. 2002;56:167-70. (Pubitemid 34174437)
30. Ikäheimo P, Hartikainen S, Tuuponen T, Kiuttu J, Klaukka T. Comorbidity and medication load in adult asthmatics. Scand J Prim Health Care. 2005;23:88-94. (Pubitemid 40904663)
31. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64:728-35.